Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation

NCT ID: NCT05870020

Last Updated: 2024-06-04

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 146 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-05-24
• Study Completion Date: 2027-01-31

Brief Summary

In spite of a growing interest in the evaluation of health-related quality of life in movement's disorders management, there is no tool specifically dedicated to dystonia and related syndromes that measures both the objective severity of the handicap and the patient's feelings about the surgical treatment in terms of subjective improvement. We have been working for several years at the bedside of patients operated on in the " pathologies cérébrales résistantes " Unit on the development of a related questionnaire to assess both the motor severity and the patients' feelings about the evolution of their disease under Deep Brain Stimulation (DBS).

The self-questionnaire designed would allow to a certain extent to get away from the two gold standards currently used in the field, i.e. the Burke, Fahn & Marsden Dystonia Rating Scale (BFMDRS) and the SF-36, thus facilitating the evaluation and allowing a homogenization of the practices for the different implanting centers on the french territory.

Detailed Description

The construction of the tool in its particular design, including various targeted modules, stems from an experience of more than ten years acquired with patients treated by deep brain stimulation in the unit. The self-questionnaire thus obtained will be sent to 146 patients with generalized dystonodyskinetic syndrome, operated and followed in the unit, and submitted to various statistical analyses. The scores of the identified dimensions will be compared with the etiology of the abnormal movements (primary vs. secondary) as well as with the results obtained with the two scales currently used to evaluate abnormal movements (BFMDRS) and/or quality of life (SF-36) and finally with the patients' mood during their follow-up (BDI, STAI). Tolerance to surgery will also be measured.

Conditions

Dystono-dyskinetic Syndromes

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Adults with dystono-diskinetic syndrome treated by depp brain stimulation in the unit.

Group Type: EXPERIMENTAL

Questionnaire (DBS-QoLs)

Intervention Type: OTHER

The DBS-QoLs questionnaire will be sent to the patients for answer:

The questonnaire will be sent at :

• the inclusion
• 15 days after the inclusion
• 1 year after the inclusion

Interventions

Questionnaire (DBS-QoLs)

The DBS-QoLs questionnaire will be sent to the patients for answer:

The questonnaire will be sent at :

• the inclusion
• 15 days after the inclusion
• 1 year after the inclusion

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Adulte between 18 an 80 years
• Patient with a generalized dystono-dyskinetic syndrome treated by Electrical Neuromodulation Continue and follow-up in the unit
• Subject affiliated to the French social security system

Exclusion Criteria

• non-French speaker
• patients who are physically unable to answer the questionnaire and who have no trusted person to help
• severe cognitive impairment (MoCA <10, MDRS <123, PM-38 <70)
• lack of informed consent

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Montpellier

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

CHU Montpellier

Montpellier, Hérault, France

Site Status: RECRUITING

Countries

France

Facility Contacts

Emily SANREY

Role: primary

e-sanrey@chu-montpellier.fr

04 67 33 74 45

Other Identifiers

RECHMPL22_0228

Identifier Type: -

Identifier Source: org_study_id